Overview
Christie Matthaei represents various clients in all aspects of intellectual property disputes, with a focus on patent litigation. She also counsels clients on pre-litigation matters, including analyzing patent infringement and validity.
Christie earned her J.D. from the George Washington University Law School, where she was a member of the American Intellectual Property Law Association Journal. During her time in law school, she interned for the White House, working in the Office of Science and Technology Policy.
Prior to law school, Christie worked at Pacific Northwest National Laboratory as a chemical engineer on projects related to alternative energy and green chemicals. She obtained a B.S. in Chemical Engineering from the University of Washington.
Education
- The George Washington University Law School (J.D., 2011)
- University of Washington (UW) (B.S. Chemical Engineering, 2007)
Representative Matters
Global Shade Corp. v. With-U E-Commerce (Shanghai) Co., Ltd., IPR2021-00365 (Pat. Trial & Appeal Bd. 2022)
On behalf of Petitioner Global Shade in an inter partes review, successfully obtained a final written decision invalidating each of the claims asserted in a co-pending district court litigation. The invalidated claims were directed to a collapsible canopy with a central lock.
Jazz Pharmaceuticals, Inc., et al. v. Amneal Pharmaceuticals, LLC et al., Case Nos. 13-cv-00391 and 15-cv-08229 (2016).
Represented the Ranbaxy defendants in a patent infringement action in the District of New Jersey on patents relating to sodium oxybate (the active ingredient in Jazz’s XYREM® product) and patents relating to the REMS system for the product. Achieved favorable case-dispositive settlement for client.
Recognition
Awards & Honors
- Recognized in Profiles in Diversity Journal for “Asian Leadership and Women Worth Watching in STEM” (2024)
- Named to the Best Lawyers: Ones to Watch guide, which “recognizes lawyers who are earlier in their careers for their outstanding professional excellence in private practice”, for Patent Law (2021 – 2025) and Intellectual Property Litigation and Patent Litigation (2023 – 2025)
Affiliations
- Washington State Patent Lawyers Association
- King County Bar Association
News & Insights
Articles
Blog Writer, KnobbeMedical.com Blog (2013 – Present)
Medical Device Manufacturer’s Association Comments on Senate Hearing
Mechanical Ventilation Innovation Challenge
House Committee Passes Innovation Act – Medical Device Group Expresses Opposition
USPTO Medical Device Technology Fair
Medical Device Industry Organizations Support STRONG Patents Act
Federal Circuit Issues an Opinion in 40 year Dispute over “Gore-Tex” Blood Vessel Graft Patent
Federal Circuit Finds Antares’ Patent Claims Invalid for Failure to Satisfy the “Original Patent” Requirement
Medical Device Manufacturer’s Association Submits Comments on USPTO’s Proposed Rule to Require Identification of Attributable Ownership
Medtronic Announces Invalidation of Edwards Spenser European Heart Valve Patent
United States Supreme Court Reverses Federal Circuit Decision in Medtronic, Inc. v. Mirowski Family Ventures, LLC
Cynosure Announces Settlement of Patent Infringement Lawsuits Against Tria Beauty
USPTO Grants Lombard’s Request to Dismiss Inter Partes Review of U.S. Patent No. 6,306,141
Blog Writer, Knobbe Martens Litigation Blog (2018 – Present)
- Commissioner’s Exercise of Vacant Director’s Duties Does Not Violate Appointments Clause
- Notice Letters and Communications May Form a Basis for Personal Jurisdiction
- PTAB Should Analyze Patentability Even if Claims Are Indefinite
- A Generic Motivation Is Still a Motivation
- Stanford’s Computer Models – Inventive for Parents, but Not for Patents
- If You Buy the Whole Company, You Can Fight Its Legal Battles
- Non-Infringement Need Not Be “Actually Litigated” to Shield Accused Products From Infringement Liability in Subsequent Actions
- The Disclosure-Dedication Doctrine Applies Even When Disclosure Relates to a Different, Unclaimed Embodiment
- Competing Evidence Regarding Whether Reference Qualifies as Primary Reference Precludes Summary Judgment of Obviousness of a Design Patent
- Using the Intrinsic Record to Resolve Alice Step One
- Claims Using Naturally-Occurring Phenomenon in Method of Preparation Found Patent Eligible
- Expert Testimony Must Be Tethered to Supporting Evidence
- Evidence from Non-Instituted Grounds Not Permitted in Final Written Decision at PTAB
- Prosecution History Estoppel Bars Infringement Claim Under Doctrine of Equivalents